切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - AChE - NTPDases - CB1 Receptors - 5-HT7 Receptors

10 件产品

每页
清除全部
  1. PSB 06126
    B7113 PSB 06126
    Target: NTPDases
    Summary: NTPDase 3抑制剂
      <46.64 mg/mL
      <23.32 mg/mL
  2. AM251
    B1427 AM251
    Target: CB1 Receptors
    Summary: 有效的CB1拮抗剂
      ≥55.5 mg/mL
      insoluble in H2O
  3. Donepezil HCl
    B1602 Donepezil HCl
    中文名: 盐酸多奈哌齐
    Target: AChE
    Summary: AChE抑制剂
      insoluble in DMSO
      ≥10.4 mg/mL
  4. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  5. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  6. Rimonabant
    B1429 Rimonabant
     3 Citation
    中文名: 利莫那班
    Target: CB1 Receptors|CB2 Receptors
    Summary: CB1 受体拮抗剂
      ≥23.19 mg/mL
      insoluble in H2O
  7. Org 27569
    B1426 Org 27569
    Target: CB1 Receptors
    Summary: 大麻素CB1受体别构调节剂
      ≥13.95 mg/mL
      insoluble in H2O
  8. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  9. Galanthamine
    A3423 Galanthamine
     2 Citation
    中文名: 加兰他敏
    Target: AChE
    Summary: 乙酰胆碱酯酶抑制剂
      ≥14.37 mg/mL
      ≥14.43 mg/mL
  10. (-)-Huperzine A
    A1932 (-)-Huperzine A
    中文名: 石杉碱甲
    Target: NMDA Receptors|AChE
    Summary: NMDA受体拮抗剂/AChE抑制剂
      ≥12.12 mg/mL
      insoluble in H2O

10 件产品

每页